Symrise AG (SY1.DE)
Holzminden, DE
Symrise AG is a German-based specialist in providing a comprehensive array of ingredients, encompassing fragrances, flavor compounds, active cosmetic components, and functional raw materials. Its operations are structured into two principal divisions: Taste, Nutrition & Health, and Scent & Care. The 'Taste, Nutrition & Health' division focuses on delivering flavor solutions and functional ingredients for the food and beverage industry, along with savory flavorings. It supplies natural and sustainable ingredients for diverse applications such as baby food and dietary supplements. This segment also extends its offerings to specialized product solutions and services for pet food and aqua feed manufacturers, in addition to providing probiotics for use in food supplements and functional foods. Conversely, the 'Scent & Care' segment is dedicated to the development, production, and sale of fragrance components, aroma molecules, cosmetic ingredients, and mint flavors, including their specific application technologies. Products from this segment are integral to a wide range of consumer goods, serving manufacturers of perfumes, personal care items, cosmetics, cleaning products, detergents, air fresheners, and oral hygiene products. Symrise AG maintains a broad international presence, conducting business across Europe, Africa, the Middle East, North America, Asia Pacific, and Latin America. The company was established in 1874 and has its headquarters in Holzminden, Germany.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.44% | -1.30% | +5.13% | +1.96% | +10.72% | +15.71% | -25.24% | -20.88% | -27.10% | +40.27% | +327.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 9 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | -1 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-1.4% Q4'25: +95.3% (vs Q3'24)
-
EPS growth Chemicals - Specialty: +13.2%-48.0% Q4'25: -116.3% (vs Q3'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.4% Q4'25: +20.0% (vs Q3'24)
-
EBIT margin Chemicals - Specialty: +8.8%+12.4% ★ Q4'25: +8.2% (vs Q3'24)
-
ROIC Chemicals - Specialty: +5.6%+7.3% ★ Q4'25: +8.8% (vs Q3'24)
-
Share dilution Chemicals - Specialty: +0.1%+0.2% Q4'25: -2.5% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.88× Q4'25: 1.90× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 16 Rev. Ana. 11 EPS Ana. |
Dec 2027 17 Rev. Ana. 11 EPS Ana. |
Dec 2028 14 Rev. Ana. 8 EPS Ana. |
Dec 2029 9 Rev. Ana. 6 EPS Ana. |
Dec 2030 13 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.23B
est: 1.25B (-1.7%)
|
1.27B
est: 1.30B (-2.3%)
|
1.32B
est: 1.33B (-0.7%)
|
1.36B
est: 1.38B (-1.2%)
|
1.57B
est: 1.58B (-0.4%)
|
1.58B
est: 1.60B (-1.2%)
|
1.73B
est: 1.74B (-0.4%)
|
1.83B
est: 1.86B (-1.8%)
|
2.12B
est: 2.12B (+0.0%)
|
2.60B
est: 2.60B (+0.0%)
|
2.90B
est: 2.90B (+0.1%)
|
3.00B
est: 3.01B (-0.6%)
|
3.15B
est: 3.14B (+0.4%)
|
3.41B
est: 3.40B (+0.2%)
|
3.52B
est: 3.54B (-0.5%)
|
3.83B
est: 3.81B (+0.5%)
|
4.62B
est: 4.60B (+0.3%)
|
4.73B
est: 4.88B (-3.1%)
|
5.00B
est: 4.99B (+0.2%)
|
4.93B
est: 4.93B (+0.0%)
|
4.97B
4.87B – 5.09B
+0.9% YoY
|
5.22B
5.07B – 5.41B
+4.9% YoY
|
5.49B
5.48B – 5.51B
+5.3% YoY
|
5.80B
5.66B – 5.98B
+5.7% YoY
|
6.18B
6.02B – 6.37B
+6.5% YoY
|
| EBITDA |
1.08B
est: 243.84M (+344.0%)
|
276.97M
est: -260.42M (+206.4%)
|
268.14M
est: 178.66M (+50.1%)
|
264.45M
est: 175.02M (+51.1%)
|
343.38M
est: 187.15M (+83.5%)
|
317.80M
est: 218.06M (+45.7%)
|
338.40M
est: 258.76M (+30.8%)
|
370.83M
est: 292.67M (+26.7%)
|
432.19M
est: 353.06M (+22.4%)
|
576.58M
est: 446.97M (+29.0%)
|
600.36M
est: 566.78M (+5.9%)
|
627.91M
est: 537.68M (+16.8%)
|
630.55M
est: 547.60M (+15.1%)
|
702.81M
est: 589.49M (+19.2%)
|
735.96M
est: 638.35M (+15.3%)
|
806.40M
est: 673.25M (+19.8%)
|
780.50M
est: 709.88M (+9.9%)
|
841.49M
est: 927.49M (-9.3%)
|
1.04B
est: 945.51M (+10.0%)
|
907.87M
est: 936.26M (-3.0%)
|
944.94M
924.43M – 966.12M
+0.9% YoY
|
991.30M
962.74M – 1.03B
+4.9% YoY
|
1.04B
1.04B – 1.05B
+5.3% YoY
|
1.10B
1.07B – 1.14B
+5.7% YoY
|
1.17B
1.14B – 1.21B
+6.5% YoY
|
| EBIT |
1.00B
est: 162.33M (+517.4%)
|
202.69M
est: 86.04M (+135.6%)
|
227.44M
est: 199.45M (+14.0%)
|
177.90M
est: 194.00M (-8.3%)
|
250.80M
est: 186.58M (+34.4%)
|
236.29M
est: 249.04M (-5.1%)
|
252.18M
est: 253.57M (-0.5%)
|
280.82M
est: 270.31M (+3.9%)
|
303.98M
est: 321.90M (-5.6%)
|
399.61M
est: 373.92M (+6.9%)
|
399.89M
est: 452.66M (-11.7%)
|
429.33M
est: 417.73M (+2.8%)
|
431.12M
est: 449.47M (-4.1%)
|
460.95M
est: 469.06M (-1.7%)
|
481.39M
est: 496.77M (-3.1%)
|
552.72M
est: 523.93M (+5.5%)
|
490.03M
est: 552.43M (-11.3%)
|
552.39M
est: 620.81M (-11.0%)
|
724.16M
est: 632.87M (+14.4%)
|
609.30M
est: 626.68M (-2.8%)
|
632.48M
618.76M – 646.66M
+0.9% YoY
|
663.52M
644.40M – 688.52M
+4.9% YoY
|
698.54M
696.87M – 700.21M
+5.3% YoY
|
738.01M
719.30M – 760.33M
+5.7% YoY
|
785.78M
765.86M – 809.54M
+6.5% YoY
|
| Net Income |
-89.85M
est: 67.48M (-233.2%)
|
97.44M
est: -93.66M (+204.0%)
|
90.39M
est: 99.27M (-8.9%)
|
84.35M
est: 93.78M (-10.1%)
|
133.50M
est: 96.49M (+38.3%)
|
146.54M
est: 136.03M (+7.7%)
|
157.49M
est: 158.48M (-0.6%)
|
172.34M
est: 168.54M (+2.3%)
|
185.00M
est: 195.92M (-5.6%)
|
246.78M
est: 230.39M (+7.1%)
|
252.71M
est: 282.65M (-10.6%)
|
270.27M
est: 261.19M (+3.5%)
|
275.33M
est: 281.47M (-2.2%)
|
298.31M
est: 297.59M (+0.2%)
|
306.87M
est: 319.25M (-3.9%)
|
374.92M
est: 336.70M (+11.4%)
|
280.01M
est: 238.74M (+17.3%)
|
340.47M
est: 392.39M (-13.2%)
|
478.20M
est: 470.05M (+1.7%)
|
249.30M
est: 501.46M (-50.3%)
|
540.90M
471.61M – 586.23M
+7.9% YoY
|
595.09M
504.07M – 652.73M
+10.0% YoY
|
641.73M
591.70M – 683.41M
+7.8% YoY
|
685.04M
662.46M – 711.96M
+6.7% YoY
|
711.48M
688.04M – 739.45M
+3.9% YoY
|
| SGA |
-211.80M
est: 254.76M (-183.1%)
|
-215.72M
est: 381.20M (-156.6%)
|
289.29M
est: 299.32M (-3.4%)
|
310.73M
est: 300.13M (+3.5%)
|
335.95M
est: 355.65M (-5.5%)
|
322.63M
est: 342.38M (-5.8%)
|
348.07M
est: 348.98M (-0.3%)
|
374.99M
est: 372.50M (+0.7%)
|
465.48M
est: 426.40M (+9.2%)
|
575.40M
est: 560.13M (+2.7%)
|
627.28M
est: 656.78M (-4.5%)
|
632.79M
est: 649.83M (-2.6%)
|
654.67M
est: 659.00M (-0.7%)
|
732.51M
est: 707.60M (+3.5%)
|
736.72M
est: 783.93M (-6.0%)
|
784.71M
est: 826.79M (-5.1%)
|
938.54M
est: 871.77M (+7.7%)
|
951.62M
est: 986.91M (-3.6%)
|
998.11M
est: 1.01B (-0.8%)
|
993.85M
est: 996.25M (-0.2%)
|
1.01B
983.65M – 1.03B
+0.9% YoY
|
1.05B
1.02B – 1.09B
+4.9% YoY
|
1.11B
1.11B – 1.11B
+5.3% YoY
|
1.17B
1.14B – 1.21B
+5.7% YoY
|
1.25B
1.22B – 1.29B
+6.5% YoY
|
| EPS |
-0.76
est: 0.48 (-257.5%)
|
0.82
est: 1.18 (-30.5%)
|
0.76
est: 0.91 (-16.3%)
|
0.71
est: 0.95 (-25.0%)
|
1.10
est: 1.30 (-15.6%)
|
1.24
est: 1.32 (-5.9%)
|
1.33
est: 1.48 (-10.1%)
|
1.46
est: 1.55 (-6.0%)
|
1.48
est: 1.63 (-9.5%)
|
1.90
est: 1.98 (-4.3%)
|
1.94
est: 1.92 (+0.9%)
|
2.08
est: 2.14 (-2.7%)
|
2.12
est: 2.11 (+0.6%)
|
2.16
est: 2.27 (-5.0%)
|
2.27
est: 2.37 (-4.4%)
|
2.74
est: 2.69 (+1.8%)
|
2.00
est: 3.18 (-37.0%)
|
2.44
est: 2.81 (-13.1%)
|
3.42
est: 3.35 (+2.2%)
|
1.78
est: 3.62 (-50.8%)
|
3.80
3.37 – 4.19
+5.1% YoY
|
4.19
3.60 – 4.66
+10.3% YoY
|
4.49
4.22 – 4.88
+7.2% YoY
|
4.89
4.73 – 5.08
+8.9% YoY
|
5.08
4.91 – 5.28
+3.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 463.5K +4.0K (+0.9%) | 37.49M -2.5M (-6.2%) | 0.33% +0.003 pp | 0.08% -0.002 pp | EUR102.92 -33.1% | 15 qtrs — |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jean-Yves Parisot | CEO & Member of Executive Board | 2M | — |
| Michael Bjorn Friede | President Scent & Care and Member of Executive Board | 1M | male |
| Olaf Klinger | CFO, & President of Finance & IT Department IT Department and Member of Executive Board | 1M | male |
| Stephanie Cossmann | Member of the Executive Board and President of HR, Legal & Sustainability | 1M | — |
| Walter Ribeiro | Member of Executive Board & President of Taste, Nutrition & Health | 1M | male |
| Marie-Laure Roumiguiere | Head of Global Account Management of EAME - Cosmetic Ingredients Division | — | female |
| Rene Weinberg | Head of Investor Relations | — | — |
| Roberto Ascoli | Senior Vice President of New Business Development - Scent & Care Division | — | male |
| Jurgen Nienhaus | Corporate Vice President of Operations | — | — |
| Arnaud Bellon | Senior Vice President and Global Head of Botanicals & Colors - The Cosmetic Ingredients Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SY1.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
